Skip to content
Clinical Trials – home
HungaryBack to Hungary

Clinical trials in Encs – page 27

342 clinical trials in Encs, Hungary across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Encs at a glance
342
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

342 trials in Encs

Open in trial search

Asthma

Not recruiting

Study on the Effectiveness and Safety of Tanimilast for Patients with Uncontrolled Asthma on Inhaled Corticosteroid and Long-Acting Beta2-Agonist Therapy

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Tanimilast
  • Sponsor:Chiesi Farmaceutici S.p.A.

Dermatitis atopic

Not recruiting

Study of Upadacitinib for Adolescents and Adults with Moderate to Severe Eczema

Investigational
Countries:HungaryHungary
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Upadacitinib
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Study of Pembrolizumab with Chemotherapy for High-Risk Early-Stage ER+/HER2- Breast Cancer Patients

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Doxorubicin
  • Sponsor:Merck Sharp & Dohme LLC

Dysmenorrhoea

Not recruiting

Study on the Effectiveness of Chaste Tree Extract (Vitex agnus-castus BNO 1095) for Women with Menstrual Cramps (Primary Dysmenorrhea)

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years
  • Substances:Dry Extract From Chaste Tree Fruits (7-11:1), Extraction Solvent: Ethanol 70% (V/V)
  • Sponsor:Bionorica SE

Chronic hepatitis B+1

Not recruiting

Study of Bepirovirsen for Patients with Chronic Hepatitis B on Nucleos(t)ide Analogue Treatment

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Bepirovirsen
  • Sponsor:Glaxosmithkline Research & Development Limited

Breast cancer+2

Not recruiting

Study on Giredestrant and Fulvestrant with CDK4/6 Inhibitor for Patients with ER+ HER2-Negative Advanced Breast Cancer Resistant to Endocrine Therapy

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:F. Hoffmann-La Roche AG

Psoriasis

Not recruiting

Study on Guselkumab and Etanercept for Treating Chronic Plaque Psoriasis in Children Aged 6 to 17 Years

Registered drug
Countries:HungaryHungary
  • Participants:0–17 years
  • Substances:Etanercept
  • Sponsor:Janssen Cilag International

Study on Ertugliflozin for Children and Teens with Type 2 Diabetes

Investigational
Countries:HungaryHungary
  • Participants:0–17 years
  • Substances:Ertugliflozin
  • Sponsor:Merck Sharp & Dohme LLC

Colitis ulcerative+2

Not recruiting

Study on Long-term Safety of Ustekinumab for Children with Crohn's Disease, Juvenile Psoriatic Arthritis, or Ulcerative Colitis

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:0–17 years
  • Substances:Ustekinumab
  • Sponsor:Janssen Cilag International

Breast cancer

Not recruiting

Study Comparing ARV-471 and Fulvestrant for Patients with Advanced Estrogen Receptor-Positive, HER2-Negative Breast Cancer After Endocrine Treatment

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Fulvestrant
  • Sponsor:Pfizer Inc.

Colitis ulcerative

Not recruiting

Study on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Obefazimod
  • Sponsor:Abivax

Bladder cancer

Not recruiting

Study of Pembrolizumab with Chemoradiotherapy for Patients with Muscle-Invasive Bladder Cancer

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:Merck Sharp & Dohme LLC

Other cities in Hungary

The busiest research cities in the country

All 73 cities in Hungary

Clinical research in Encs

What the registry says about research in the country

01 Cardiovascular & Metabolic Research

Innovative trials exploring treatments for atherosclerotic cardiovascular disease and blood pressure management in patients with chronic kidney disease. Studies focus on improving cardiovascular outcomes and reducing health risks.

  • Chronic Kidney Disease with Hypertension
  • Atherosclerotic Cardiovascular Disease
  • Severe Hypertriglyceridemia

Multiple studies evaluating new therapeutic approaches for lipid management and cardiovascular risk reduction.

02 Dermatology & Rheumatology

Clinical research targeting chronic inflammatory conditions, including studies of atopic dermatitis and arthritis treatments. Evaluating long-term safety and efficacy of novel therapies.

  • Moderate to Severe Atopic Dermatitis
  • Psoriatic Arthritis
  • Rheumatoid Arthritis

Investigating advanced treatment options for patients with inadequate response to conventional therapies.

03 Respiratory Medicine

Advanced research into chronic obstructive pulmonary disease management, particularly focusing on patients with frequent exacerbations and specific biomarker profiles.

  • Moderate to Very Severe COPD
  • COPD with Frequent Exacerbations

Studies aim to reduce exacerbation frequency and improve quality of life for respiratory patients.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.